BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 19656076)

  • 21. Primary immunosuppression regimen of rapid steroid withdrawal after living related liver transplantation: a single-center experience.
    Toyoki Y; Hakamada K; Narumi S; Totsuka E; Nara M; Ono H; Ishizawa Y; Sasaki M
    Transplant Proc; 2004 Oct; 36(8):2279-81. PubMed ID: 15561218
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An objective measure to identify pediatric liver transplant recipients at risk for late allograft rejection related to non-adherence.
    Venkat VL; Nick TG; Wang Y; Bucuvalas JC
    Pediatr Transplant; 2008 Feb; 12(1):67-72. PubMed ID: 18186891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relation between mRNA expression level of multidrug resistance 1/ABCB1 in blood cells and required level of tacrolimus in pediatric living-donor liver transplantation.
    Goto M; Masuda S; Kiuchi T; Ogura Y; Oike F; Tanaka K; Uemoto S; Inui K
    J Pharmacol Exp Ther; 2008 May; 325(2):610-6. PubMed ID: 18252812
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tacrolimus-induced elevation in plasma triglyceride concentrations after administration to renal transplant patients is partially due to a decrease in lipoprotein lipase activity and plasma concentrations.
    Tory R; Sachs-Barrable K; Goshko CB; Hill JS; Wasan KM
    Transplantation; 2009 Jul; 88(1):62-8. PubMed ID: 19584682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of hepatitis C infection on tacrolimus doses and blood levels in liver transplantation recipients.
    Trotter JF; Osborne JC; Heller M; Christians U
    Aliment Pharmacol Ther; 2005 Jul; 22(1):37-44. PubMed ID: 15963078
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The interaction between antiretroviral agents and tacrolimus in liver and kidney transplant patients.
    Jain AK; Venkataramanan R; Shapiro R; Scantlebury VP; Potdar S; Bonham CA; Ragni M; Fung JJ
    Liver Transpl; 2002 Sep; 8(9):841-5. PubMed ID: 12200788
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and histological analysis of acute tacrolimus (TAC) nephrotoxicity in renal allografts.
    Shimizu T; Tanabe K; Tokumoto T; Ishikawa N; Shinmura H; Oshima T; Toma H; Yamaguchi Y
    Clin Transplant; 1999; 13 Suppl 1():48-53. PubMed ID: 10751057
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and histological analysis of chronic tacrolimus nephrotoxicity in renal allografts.
    Shimizu T; Ishida H; Shirakawa H; Omoto K; Tanabe K; Yamaguchi Y
    Transplant Proc; 2008 Sep; 40(7):2370-2. PubMed ID: 18790237
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tacrolimus dosing requirements and concentrations in adult living donor liver transplant recipients.
    Taber DJ; Dupuis RE; Fann AL; Andreoni KA; Gerber DA; Fair JH; Johnson MW; Shrestha R
    Liver Transpl; 2002 Mar; 8(3):219-23. PubMed ID: 11910566
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of CYP3A5 polymorphisms on the pharmacokinetics of tacrolimus in adolescent kidney transplant recipients.
    Tirelli S; Ferraresso M; Ghio L; Meregalli E; Martina V; Belingheri M; Mattiello C; Torresani E; Edefonti A
    Med Sci Monit; 2008 May; 14(5):CR251-254. PubMed ID: 18443548
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of albumin supplementation on tacrolimus and cyclosporine therapy early after liver transplantation.
    Trull A; Hughes V; Cooper D; Wilkins M; Gimson A; Friend P; Johnston A; Sharples L; Park G
    Liver Transpl; 2002 Mar; 8(3):224-32. PubMed ID: 11910567
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dyslipidemia during sirolimus therapy in liver transplant recipients occurs with concomitant cyclosporine but not tacrolimus.
    Trotter JF; Wachs ME; Trouillot TE; Bak T; Kugelmas M; Kam I; Everson G
    Liver Transpl; 2001 May; 7(5):401-8. PubMed ID: 11349259
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Higher initial tacrolimus blood levels and concentration-dose ratios in kidney transplant recipients who develop diabetes mellitus.
    Rodrigo E; de Cos MA; Fernández-Fresnedo G; Sánchez B; Ruiz JC; Piñera C; Palomar R; Cotorruelo JG; Gómez-Alamillo C; de Castro SS; de Francisco AL; Arias M
    Transplant Proc; 2005 Nov; 37(9):3819-20. PubMed ID: 16386549
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tacrolimus monotherapy in liver transplantation: one-year results of a prospective, randomized, double-blind, placebo-controlled study.
    Lerut J; Mathys J; Verbaandert C; Talpe S; Ciccarelli O; Lemaire J; Bonaccorsi-Riani E; Vanthuyne V; Hetsch N; Roggen F; Reyck CD; Goffette P; Latinne D; Orlando G; Rahier J; Sempoux C; Wallemacq P; Laterre PF; Gianello P
    Ann Surg; 2008 Dec; 248(6):956-67. PubMed ID: 19092340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful withdrawal of prednisone after adult liver transplantation for autoimmune hepatitis.
    Trouillot TE; Shrestha R; Kam I; Wachs M; Everson GT
    Liver Transpl Surg; 1999 Sep; 5(5):375-80. PubMed ID: 10477838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated tacrolimus trough levels in association with mycophenolate mofetil-induced diarrhea: a case report.
    Frühwirth M; Fischer H; Simma B; Ellemunter H
    Pediatr Transplant; 2001 Apr; 5(2):132-4. PubMed ID: 11328552
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coadministration of Erythromycin to Increase Tacrolimus Concentrations in Liver Transplant Recipients.
    Chiang LH; Wu TH; Tsai TC; Lee WC
    Transplant Proc; 2019 Jun; 51(5):1439-1441. PubMed ID: 31155178
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tacrolimus as a part of immunosuppressive treatment in kidney transplantation patients: sex differences.
    Velickovic-Radovanovic R; Mikov M; Catic-Djordjevic A; Stefanovic N; Stojanovic M; Jokanovic M; Cvetkovic T
    Gend Med; 2012 Dec; 9(6):471-80. PubMed ID: 23141295
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of Schisandra sphenanthera extract on the concentration of tacrolimus in the blood of liver transplant patients.
    Jiang W; Wang X; Xu X; Kong L
    Int J Clin Pharmacol Ther; 2010 Mar; 48(3):224-9. PubMed ID: 20197017
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of long-term co-administration of Wuzhi tablet (Schisandra sphenanthera extract) and prednisone on the pharmacokinetics of tacrolimus.
    Qin XL; Yu T; Li LJ; Wang Y; Gu HM; Wang YT; Huang M; Bi HC
    Phytomedicine; 2013 Feb; 20(3-4):375-9. PubMed ID: 23267661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.